How do I manage nausea on a GLP-1?

Nausea is the most common reason people abandon a GLP-1, and it is largely preventable. On the Zepbound label nausea affects 25 to 29 percent of patients, and it follows a predictable rhythm: it appears in the days after a dose increase, peaks, then fades. The single most effective response is to change the escalation schedule, not to change the drug.

Slow the escalation before you do anything else

Tirzepatide starts at 2.5 mg weekly for four weeks and increases in 2.5 mg steps after at least four weeks at the current dose. Injectable semaglutide moves through 0.25, 0.5, 1.0 and 1.7 mg at four week intervals before reaching 2.4 mg. Oral semaglutide escalates every 30 days. In every case the interval is a minimum, not a maximum. Staying at a tolerated dose for eight or twelve weeks instead of four is a legitimate clinical decision, and it usually converts an intolerable drug into a tolerable one without sacrificing much weight loss.

What to change about eating

Delayed gastric emptying means a normal-sized meal now sits in a stomach that is working more slowly. Smaller volumes eaten more often work better than three full meals. Fat slows gastric emptying further, so a high fat meal on top of a GLP-1 is the most reliable way to provoke symptoms. Eat protein first while your appetite window is open, because protein intake is the part of the diet that protects muscle during weight loss and it is the first thing people drop when they feel sick. Sip fluids through the day rather than drinking large volumes at meals. Strong smells, alcohol and lying down soon after eating all make it worse.

When nausea is not just a side effect

Nausea that arrives out of the blue at a stable dose, nausea with severe abdominal pain, or vomiting that stops you keeping fluids down are different problems. Persistent vomiting causes volume depletion and acute kidney injury, which is a labelled warning for both drugs. If you are having surgery or an endoscopy, tell the anaesthetist you are on a GLP-1: the 2024 multi-society guidance advises that most patients continue the medication, with a liquid-only diet for 24 hours before the procedure in those at highest risk of gastrointestinal symptoms.

Give any change two weeks before judging it. If nausea is still severe more than seven days after every dose step, ask your prescriber to hold the dose rather than push through, and ask whether an anti-nausea medication is appropriate for the escalation weeks only.